SEDACORON SOLUTION FOR INJECTION 5PCS

Based on information gathered from leading pharmaceutical platforms like Nahdionline, , and , Sedacoron Solution for Injection is a critical medication used in the management of severe cardiac arrhythmias. This product, manufactured by Sanofi, provides a potent antiarrhythmic agent for hospital use.

Product Details

Sedacoron Solution for Injection contains Amiodarone Hydrochloride, a class III antiarrhythmic drug. It is presented in a pack of 5 ampoules, each containing 150 mg of Amiodarone Hydrochloride in 3 mL of solution. This formulation is designed for intravenous administration to manage life-threatening ventricular and supraventricular arrhythmias that have not responded to other treatments or when other treatments are contraindicated. Its mechanism involves prolonging the cardiac action potential and refractory period, leading to stabilization of heart rhythm.

Benefits of Use

• Effective in controlling severe and refractory ventricular arrhythmias (e.g., recurrent ventricular tachycardia, ventricular fibrillation).
• Useful in managing supraventricular arrhythmias, particularly atrial fibrillation with rapid ventricular response when other agents are ineffective or contraindicated.
• Helps maintain normal sinus rhythm after cardioversion in patients with atrial fibrillation.
• Offers a broad spectrum antiarrhythmic action, making it a valuable option in emergency cardiac care.

How to Use

1. Sedacoron Solution for Injection must be administered by healthcare professionals in a hospital setting.
2. The usual route of administration is intravenous (IV) infusion.
3. Dosage is individualized based on the patient's condition, weight, and response, typically starting with a loading dose followed by a maintenance infusion.
4. Each ampoule (150 mg/3 mL) must be diluted in 5% Dextrose solution before administration; it should not be mixed with saline solutions.
5. Continuous ECG and blood pressure monitoring are essential during administration due to potential cardiac side effects.

Caution & Warnings

• Sedacoron has a long half-life and can accumulate in tissues, leading to delayed onset and prolonged duration of side effects.
• Requires careful monitoring for cardiac adverse effects including bradycardia, hypotension, and exacerbation of arrhythmias.
• Risk of pulmonary toxicity (e.g., interstitial pneumonitis, fibrosis) which can be severe and life-threatening; regular pulmonary function tests may be necessary.
• Can cause liver dysfunction, including elevated liver enzymes and hepatitis; liver function should be monitored.
• May affect thyroid function, leading to hypo- or hyperthyroidism; thyroid function tests are recommended.
• Photosensitivity is a common side effect; patients should avoid sun exposure and use protective clothing/sunscreen.
• Numerous drug interactions exist, particularly with warfarin, digoxin, and other antiarrhythmics; dosage adjustments may be required.
• Not recommended for use during pregnancy (Category D) or lactation unless absolutely necessary, due to potential fetal/infant harm.
• Contraindicated in patients with severe sinus bradycardia, second- or third-degree AV block (unless a pacemaker is present), and cardiogenic shock.

Ingredients

Active Ingredient: Amiodarone Hydrochloride 150 mg/3 mL.

Excipients: Polysorbate 80, Benzyl Alcohol, Water for Injection, and other standard pharmaceutical excipients.